Clinical Significance of Pharmacological Prophylaxis based on the Original Risk Classification of Venous Thromboembolism after Lower Abdominal Surgery.

Q4 Medicine Hiroshima journal of medical sciences Pub Date : 2016-12-01
Manabu Shimomura, Masatoshi Kochi, Takao Hinoi, Hiroyuki Egi, Tomohiro Adachi, Tsuyoshi Kobayashi, Hirotaka Tashiro, Hideki Ohdan
{"title":"Clinical Significance of Pharmacological Prophylaxis based on the Original Risk Classification of Venous Thromboembolism after Lower Abdominal Surgery.","authors":"Manabu Shimomura,&nbsp;Masatoshi Kochi,&nbsp;Takao Hinoi,&nbsp;Hiroyuki Egi,&nbsp;Tomohiro Adachi,&nbsp;Tsuyoshi Kobayashi,&nbsp;Hirotaka Tashiro,&nbsp;Hideki Ohdan","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Pharmacological prophylaxis was not routinely administrated following gastroenterological surgery because of concerns about bleeding complications. We tried to establish the original risk classification to determine the indication for pharmacological prophylaxis for selected patients at high risk of venous thromboembolism (VTE). One hundred and fifty-six consecutive patients who underwent lower abdominal elective surgery were divided into three groups (highest, high, and low risk groups) based on the original risk classification. Pharmacological prophylaxis was indicated for patients in the highest and high risk groups. We investigated safety and efficacy of the pharmacological prophylaxis based on this classification. Sixteen patients were classified in the highest, 50 in the high, and 90 in the low risk groups. Pharmacological prophylaxis was used for 59 cases (37.8%). There was no symptomatic pulmonary embolism or major bleeding complications. There were no significant differences in the occurrence of postoperative complications, analgesia use, and median postoperative pain scores for the three groups. In the highest and high risk groups administrated pharmacological prophylaxis, fibrin degradation products (FDP) and D-dimer did not change between postoperative day 1 and day 7. These data suggested the clinical significance of the pharmacological prophylaxis based on the original risk classification.</p>","PeriodicalId":12860,"journal":{"name":"Hiroshima journal of medical sciences","volume":"65 3-4","pages":"53-59"},"PeriodicalIF":0.0000,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hiroshima journal of medical sciences","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Pharmacological prophylaxis was not routinely administrated following gastroenterological surgery because of concerns about bleeding complications. We tried to establish the original risk classification to determine the indication for pharmacological prophylaxis for selected patients at high risk of venous thromboembolism (VTE). One hundred and fifty-six consecutive patients who underwent lower abdominal elective surgery were divided into three groups (highest, high, and low risk groups) based on the original risk classification. Pharmacological prophylaxis was indicated for patients in the highest and high risk groups. We investigated safety and efficacy of the pharmacological prophylaxis based on this classification. Sixteen patients were classified in the highest, 50 in the high, and 90 in the low risk groups. Pharmacological prophylaxis was used for 59 cases (37.8%). There was no symptomatic pulmonary embolism or major bleeding complications. There were no significant differences in the occurrence of postoperative complications, analgesia use, and median postoperative pain scores for the three groups. In the highest and high risk groups administrated pharmacological prophylaxis, fibrin degradation products (FDP) and D-dimer did not change between postoperative day 1 and day 7. These data suggested the clinical significance of the pharmacological prophylaxis based on the original risk classification.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于下腹部手术后静脉血栓栓塞原始危险分级的药物预防的临床意义。
由于担心出血并发症,胃肠外科手术后不常规给予药物预防。我们试图建立最初的风险分类,以确定对静脉血栓栓塞(VTE)高危患者进行药物预防的指征。156例连续接受下腹部择期手术的患者根据最初的风险分类分为三组(最高、高、低风险组)。最高和高危组的患者应采取药物预防。我们在此基础上研究了药物预防的安全性和有效性。16例患者被分为高危组,50例为高危组,90例为低危组。药物预防59例(37.8%)。无症状性肺栓塞或大出血并发症。三组患者在术后并发症的发生、镇痛药的使用和中位术后疼痛评分方面均无显著差异。在给予药物预防的最高和高风险组中,纤维蛋白降解产物(FDP)和d -二聚体在术后第1天至第7天没有变化。这些数据提示在原有风险分类基础上进行药物预防的临床意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Hiroshima journal of medical sciences
Hiroshima journal of medical sciences Medicine-Medicine (all)
CiteScore
0.30
自引率
0.00%
发文量
0
期刊最新文献
Establishment of an antiemetic protocol for chemotherapy-induced nausea and vomiting evaluated using the Multinational Association of Supportive Care in Cancer Antiemesis Tool in colorectal cancer Low lung diffusing capacity is associated with high cardio-ankle vascular index in patients with chronic obstructive pulmonary disease Primary retroperitoneal cyst in pregnancy: A case report based on immunohistochemical analysis and literature review Incidentally found abdominal para-aortic and inferior mesenteric root lymph node metastases of prostatic adenocarcinoma in a surgical case with sigmoid colon cancer Novel Oral Derivative UD-017, a Highly Selective CDK7 Inhibitor, Exhibits Anticancer Activity by Inducing Cell-Cycle Arrest and Apoptosis in Human Colorectal Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1